Tyra Biosciences Reports Promising Financial Results and Innovative Strategies for 2025 Tyra Biosciences has shared its financial outcomes for 2025, emphasizing the launch of its 'dabogratinib 3x3' strategy aimed at developing innovative therapies for critical health conditions.

Tyra Biosciences Reports Promising Financial Results and Innovative Strategies for 2025 #United_States #Carlsbad #Tyra_Biosciences #Dabogratinib #FGFR3_Inhibitor